Open1.550 | Close1.544 |
Vol / Avg.34.425K / 345.671K | Mkt Cap3.263M |
Day Range1.480 - 1.570 | 52 Wk Range0.917 - 9.540 |
Petros Pharma Stock (NASDAQ: PTPI) stock price, news, charts, stock research, profile.
Open1.550 | Close1.544 |
Vol / Avg.34.425K / 345.671K | Mkt Cap3.263M |
Day Range1.480 - 1.570 | 52 Wk Range0.917 - 9.540 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.200 | ||||||
REV | 1.994M |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PTPI | Petros Pharma | 0.92% | 3.3M |
BXRX | Baudax Bio | -3.32% | 2.8M |
NBY | NovaBay Pharmaceuticals | -1.03% | 2M |
YCBD | cbdMD | 2.11% | 3M |
SXTP | 60 Degrees | 2.78% | 4.5M |
You can purchase shares of Petros Pharma (NASDAQ: PTPI) through any online brokerage.
Other companies in Petros Pharma’s space includes: Baudax Bio (NASDAQ:BXRX), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
There is no analysis for Petros Pharma
The stock price for Petros Pharma (NASDAQ: PTPI) is $1.5438 last updated September 27, 2023 at 7:28 PM UTC.
There is no dividend information for Petros Pharma.
Petros Pharma’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Petros Pharma.
Petros Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Petros Pharma Stock (NASDAQ: PTPI) stock price, news, charts, stock research, profile.
Open1.550 | Close1.544 |
Vol / Avg.34.425K / 345.671K | Mkt Cap3.263M |
Day Range1.480 - 1.570 | 52 Wk Range0.917 - 9.540 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.200 | ||||||
REV | 1.994M |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PTPI | Petros Pharma | 0.92% | 3.3M |
BXRX | Baudax Bio | -3.32% | 2.8M |
NBY | NovaBay Pharmaceuticals | -1.03% | 2M |
YCBD | cbdMD | 2.11% | 3M |
SXTP | 60 Degrees | 2.78% | 4.5M |
You can purchase shares of Petros Pharma (NASDAQ: PTPI) through any online brokerage.
Other companies in Petros Pharma’s space includes: Baudax Bio (NASDAQ:BXRX), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
There is no analysis for Petros Pharma
The stock price for Petros Pharma (NASDAQ: PTPI) is $1.5438 last updated September 27, 2023 at 7:28 PM UTC.
There is no dividend information for Petros Pharma.
Petros Pharma’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Petros Pharma.
Petros Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Petros Pharma Stock (NASDAQ: PTPI) stock price, news, charts, stock research, profile.
Open1.550 | Close1.544 |
Vol / Avg.34.425K / 345.671K | Mkt Cap3.263M |
Day Range1.480 - 1.570 | 52 Wk Range0.917 - 9.540 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.200 | ||||||
REV | 1.994M |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PTPI | Petros Pharma | 0.92% | 3.3M |
BXRX | Baudax Bio | -3.32% | 2.8M |
NBY | NovaBay Pharmaceuticals | -1.03% | 2M |
YCBD | cbdMD | 2.11% | 3M |
SXTP | 60 Degrees | 2.78% | 4.5M |
You can purchase shares of Petros Pharma (NASDAQ: PTPI) through any online brokerage.
Other companies in Petros Pharma’s space includes: Baudax Bio (NASDAQ:BXRX), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
There is no analysis for Petros Pharma
The stock price for Petros Pharma (NASDAQ: PTPI) is $1.5438 last updated September 27, 2023 at 7:28 PM UTC.
There is no dividend information for Petros Pharma.
Petros Pharma’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Petros Pharma.
Petros Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Petros Pharma Stock (NASDAQ: PTPI) stock price, news, charts, stock research, profile.
Open1.550 | Close1.544 |
Vol / Avg.34.425K / 345.671K | Mkt Cap3.263M |
Day Range1.480 - 1.570 | 52 Wk Range0.917 - 9.540 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.200 | ||||||
REV | 1.994M |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PTPI | Petros Pharma | 0.92% | 3.3M |
BXRX | Baudax Bio | -3.32% | 2.8M |
NBY | NovaBay Pharmaceuticals | -1.03% | 2M |
YCBD | cbdMD | 2.11% | 3M |
SXTP | 60 Degrees | 2.78% | 4.5M |
You can purchase shares of Petros Pharma (NASDAQ: PTPI) through any online brokerage.
Other companies in Petros Pharma’s space includes: Baudax Bio (NASDAQ:BXRX), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
There is no analysis for Petros Pharma
The stock price for Petros Pharma (NASDAQ: PTPI) is $1.5438 last updated September 27, 2023 at 7:28 PM UTC.
There is no dividend information for Petros Pharma.
Petros Pharma’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Petros Pharma.
Petros Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Petros Pharma Stock (NASDAQ: PTPI) stock price, news, charts, stock research, profile.
Open1.550 | Close1.544 |
Vol / Avg.34.425K / 345.671K | Mkt Cap3.263M |
Day Range1.480 - 1.570 | 52 Wk Range0.917 - 9.540 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.200 | ||||||
REV | 1.994M |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PTPI | Petros Pharma | 0.92% | 3.3M |
BXRX | Baudax Bio | -3.32% | 2.8M |
NBY | NovaBay Pharmaceuticals | -1.03% | 2M |
YCBD | cbdMD | 2.11% | 3M |
SXTP | 60 Degrees | 2.78% | 4.5M |
You can purchase shares of Petros Pharma (NASDAQ: PTPI) through any online brokerage.
Other companies in Petros Pharma’s space includes: Baudax Bio (NASDAQ:BXRX), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
There is no analysis for Petros Pharma
The stock price for Petros Pharma (NASDAQ: PTPI) is $1.5438 last updated September 27, 2023 at 7:28 PM UTC.
There is no dividend information for Petros Pharma.
Petros Pharma’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Petros Pharma.
Petros Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Petros Pharma Stock (NASDAQ: PTPI) stock price, news, charts, stock research, profile.
Open1.550 | Close1.544 |
Vol / Avg.34.425K / 345.671K | Mkt Cap3.263M |
Day Range1.480 - 1.570 | 52 Wk Range0.917 - 9.540 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.200 | ||||||
REV | 1.994M |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PTPI | Petros Pharma | 0.92% | 3.3M |
BXRX | Baudax Bio | -3.32% | 2.8M |
NBY | NovaBay Pharmaceuticals | -1.03% | 2M |
YCBD | cbdMD | 2.11% | 3M |
SXTP | 60 Degrees | 2.78% | 4.5M |
You can purchase shares of Petros Pharma (NASDAQ: PTPI) through any online brokerage.
Other companies in Petros Pharma’s space includes: Baudax Bio (NASDAQ:BXRX), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
There is no analysis for Petros Pharma
The stock price for Petros Pharma (NASDAQ: PTPI) is $1.5438 last updated September 27, 2023 at 7:28 PM UTC.
There is no dividend information for Petros Pharma.
Petros Pharma’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Petros Pharma.
Petros Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Petros Pharma Stock (NASDAQ: PTPI) stock price, news, charts, stock research, profile.
Open1.550 | Close1.544 |
Vol / Avg.34.425K / 345.671K | Mkt Cap3.263M |
Day Range1.480 - 1.570 | 52 Wk Range0.917 - 9.540 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.200 | ||||||
REV | 1.994M |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PTPI | Petros Pharma | 0.92% | 3.3M |
BXRX | Baudax Bio | -3.32% | 2.8M |
NBY | NovaBay Pharmaceuticals | -1.03% | 2M |
YCBD | cbdMD | 2.11% | 3M |
SXTP | 60 Degrees | 2.78% | 4.5M |
You can purchase shares of Petros Pharma (NASDAQ: PTPI) through any online brokerage.
Other companies in Petros Pharma’s space includes: Baudax Bio (NASDAQ:BXRX), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
There is no analysis for Petros Pharma
The stock price for Petros Pharma (NASDAQ: PTPI) is $1.5438 last updated September 27, 2023 at 7:28 PM UTC.
There is no dividend information for Petros Pharma.
Petros Pharma’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Petros Pharma.
Petros Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Petros Pharma Stock (NASDAQ: PTPI) stock price, news, charts, stock research, profile.
Open1.550 | Close1.544 |
Vol / Avg.34.425K / 345.671K | Mkt Cap3.263M |
Day Range1.480 - 1.570 | 52 Wk Range0.917 - 9.540 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.200 | ||||||
REV | 1.994M |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PTPI | Petros Pharma | 0.92% | 3.3M |
BXRX | Baudax Bio | -3.32% | 2.8M |
NBY | NovaBay Pharmaceuticals | -1.03% | 2M |
YCBD | cbdMD | 2.11% | 3M |
SXTP | 60 Degrees | 2.78% | 4.5M |
You can purchase shares of Petros Pharma (NASDAQ: PTPI) through any online brokerage.
Other companies in Petros Pharma’s space includes: Baudax Bio (NASDAQ:BXRX), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
There is no analysis for Petros Pharma
The stock price for Petros Pharma (NASDAQ: PTPI) is $1.5438 last updated September 27, 2023 at 7:28 PM UTC.
There is no dividend information for Petros Pharma.
Petros Pharma’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Petros Pharma.
Petros Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Petros Pharma Stock (NASDAQ: PTPI) stock price, news, charts, stock research, profile.
Open1.550 | Close1.544 |
Vol / Avg.34.425K / 345.671K | Mkt Cap3.263M |
Day Range1.480 - 1.570 | 52 Wk Range0.917 - 9.540 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.200 | ||||||
REV | 1.994M |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
PTPI | Petros Pharma | 0.92% | 3.3M |
BXRX | Baudax Bio | -3.32% | 2.8M |
NBY | NovaBay Pharmaceuticals | -1.03% | 2M |
YCBD | cbdMD | 2.11% | 3M |
SXTP | 60 Degrees | 2.78% | 4.5M |
You can purchase shares of Petros Pharma (NASDAQ: PTPI) through any online brokerage.
Other companies in Petros Pharma’s space includes: Baudax Bio (NASDAQ:BXRX), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
There is no analysis for Petros Pharma
The stock price for Petros Pharma (NASDAQ: PTPI) is $1.5438 last updated September 27, 2023 at 7:28 PM UTC.
There is no dividend information for Petros Pharma.
Petros Pharma’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Petros Pharma.
Petros Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.